Thousands of men with incurable prostate cancer will be offered a lifeline after an about-turn on NHS treatment.

Breakthrough for prostate cancer patients as NHS now offers life-extending drug - The new medication is suitable for patients ...

Prostate cancer (PCa) is one of the most common malignant tumors among men worldwide. Following androgen deprivation therapy ...

Prostate cancer is the second-most common cancer in men. A new study from Thomas Jefferson University uncovered a new ...

Data from a major U.S. clinical trial from the Alliance for Clinical Trials in Oncology has uncovered a genetic factor that ...

The PROSTaid group, which meets monthly at The Cradock Arms in Leicester, aims to create a support group for men so they can ...

To help meet the potentially complex needs of patients after prostate cancer treatment and offer the precision and care ...

Decades ago, doctors created a test to determine which breast cancer patients should receive hormone therapy. Now, ...

An individual-patient meta-analysis sheds light on the optimal duration of androgen deprivation therapy in men with prostate cancer on definitive radiotherapy.

University Hospitals Seidman Cancer Center researchers have developed a tool that could identify metastatic prostate cancer ...

New recommendations prioritise multiparametric MRI, safer transperineal biopsy, and earlier escalation for high-risk prostate-specific antigen relapse.

Prostate cancer is the second most commonly diagnosed cancer in men globally, according to the World Health Organisation (WHO ...